Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology?

Am J Psychiatry. 1990 May;147(5):552-64. doi: 10.1176/ajp.147.5.552.

Abstract

Response to pharmacologic treatments may identify groups of disorders with a common pathophysiology. The authors applied a treatment-response model, based on four classes of antidepressants (tricyclic types, monoamine oxidase inhibitors, serotonin uptake inhibitors, and atypical agents), to the medical literature. The model identified eight disorders that may share a pathophysiologic abnormality: major depression, bulimia, panic disorder, obsessive-compulsive disorder, attention deficit disorder with hyperactivity, cataplexy, migraine, and irritable bowel syndrome. Phenomenologic and family studies support this grouping. If the model is validated, this family of disorders, which the authors term "affective spectrum disorder," would represent one of the most prevalent diseases in the population.

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use*
  • Clinical Trials as Topic
  • Diagnosis, Differential
  • Humans
  • Mental Disorders / classification
  • Mental Disorders / diagnosis
  • Mental Disorders / drug therapy
  • Models, Theoretical
  • Mood Disorders / classification
  • Mood Disorders / diagnosis
  • Mood Disorders / drug therapy*
  • Outcome and Process Assessment, Health Care
  • Terminology as Topic

Substances

  • Antidepressive Agents